Literature DB >> 35867837

Molecular mechanism of the severe MH/CCD mutation Y522S in skeletal ryanodine receptor (RyR1) by cryo-EM.

Kavita A Iyer1, Yifan Hu1, Thomas Klose2, Takashi Murayama3, Montserrat Samsó1.   

Abstract

Ryanodine receptors (RyRs) are main regulators of intracellular Ca2+ release and muscle contraction. The Y522S mutation of RyR1 causes central core disease, a weakening myopathy, and malignant hyperthermia, a sudden and potentially fatal response to anesthetics or heat. Y522 is in the core of the N-terminal subdomain C of RyR1 and the mechanism of how this mutation orchestrates malfunction is unpredictable for this 2-MDa ion channel, which has four identical subunits composed of 15 distinct cytoplasmic domains each. We expressed and purified the RyR1 rabbit homolog, Y523S, from HEK293 cells and reconstituted it in nanodiscs under closed and open states. The high-resolution cryogenic electron microscopic (cryo-EM) three-dimensional (3D) structures show that the phenyl ring of Tyr functions in a manner analogous to a "spacer" within an α-helical bundle. Mutation to the much smaller Ser alters the hydrophobic network within the bundle, triggering rearrangement of its α-helices with repercussions in the orientation of most cytoplasmic domains. Examining the mutation-induced readjustments exposed a series of connected α-helices acting as an ∼100 Å-long lever: One end protrudes toward the dihydropyridine receptor, its molecular activator (akin to an antenna), while the other end reaches the Ca2+ activation site. The Y523S mutation elicits channel preactivation in the absence of any activator and full opening at 1.5 µM free Ca2+, increasing by ∼20-fold the potency of Ca2+ to activate the channel compared with RyR1 wild type (WT). This study identified a preactivated pathological state of RyR1 and a long-range lever that may work as a molecular switch to open the channel.

Entities:  

Keywords:  calcium channel; central core disease; excitation–contraction coupling; malignant hyperthermia; ryanodine receptor

Mesh:

Substances:

Year:  2022        PMID: 35867837      PMCID: PMC9335238          DOI: 10.1073/pnas.2122140119

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   12.779


  56 in total

1.  Structural basis for the gating mechanism of the type 2 ryanodine receptor RyR2.

Authors:  Wei Peng; Huaizong Shen; Jianping Wu; Wenting Guo; Xiaojing Pan; Ruiwu Wang; S R Wayne Chen; Nieng Yan
Journal:  Science       Date:  2016-09-22       Impact factor: 47.728

Review 2.  Mutations in RYR1 in malignant hyperthermia and central core disease.

Authors:  Rachel Robinson; Danielle Carpenter; Marie-Anne Shaw; Jane Halsall; Philip Hopkins
Journal:  Hum Mutat       Date:  2006-10       Impact factor: 4.878

3.  Mutation screening of the RYR1 gene in malignant hyperthermia: detection of a novel Tyr to Ser mutation in a pedigree with associated central cores.

Authors:  K A Quane; K E Keating; J M Healy; B M Manning; R Krivosic-Horber; I Krivosic; N Monnier; J Lunardi; T V McCarthy
Journal:  Genomics       Date:  1994-09-01       Impact factor: 5.736

4.  Activation and inhibition of skeletal RyR channels by a part of the skeletal DHPR II-III loop: effects of DHPR Ser687 and FKBP12.

Authors:  A F Dulhunty; D R Laver; E M Gallant; M G Casarotto; S M Pace; S Curtis
Journal:  Biophys J       Date:  1999-07       Impact factor: 4.033

5.  Interaction between the dihydropyridine receptor Ca2+ channel beta-subunit and ryanodine receptor type 1 strengthens excitation-contraction coupling.

Authors:  Weijun Cheng; Xavier Altafaj; Michel Ronjat; Roberto Coronado
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-15       Impact factor: 11.205

Review 6.  Congenital muscle disorders with cores: the ryanodine receptor calcium channel paradigm.

Authors:  Susan Treves; Heinz Jungbluth; Francesco Muntoni; Francesco Zorzato
Journal:  Curr Opin Pharmacol       Date:  2008-03-04       Impact factor: 5.547

7.  A retrograde signal from RyR1 alters DHP receptor inactivation and limits window Ca2+ release in muscle fibers of Y522S RyR1 knock-in mice.

Authors:  Zoita Andronache; Susan L Hamilton; Robert T Dirksen; Werner Melzer
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-25       Impact factor: 11.205

8.  Dantrolene in human malignant hyperthermia.

Authors:  M E Kolb; M L Horne; R Martz
Journal:  Anesthesiology       Date:  1982-04       Impact factor: 7.892

9.  Coordinated movement of cytoplasmic and transmembrane domains of RyR1 upon gating.

Authors:  Montserrat Samsó; Wei Feng; Isaac N Pessah; P D Allen
Journal:  PLoS Biol       Date:  2009-04-14       Impact factor: 8.029

10.  Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix.

Authors:  Dorothee Liebschner; Pavel V Afonine; Matthew L Baker; Gábor Bunkóczi; Vincent B Chen; Tristan I Croll; Bradley Hintze; Li Wei Hung; Swati Jain; Airlie J McCoy; Nigel W Moriarty; Robert D Oeffner; Billy K Poon; Michael G Prisant; Randy J Read; Jane S Richardson; David C Richardson; Massimo D Sammito; Oleg V Sobolev; Duncan H Stockwell; Thomas C Terwilliger; Alexandre G Urzhumtsev; Lizbeth L Videau; Christopher J Williams; Paul D Adams
Journal:  Acta Crystallogr D Struct Biol       Date:  2019-10-02       Impact factor: 7.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.